Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more.
So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.
How Artificial Sweeteners Could Be Linked to Heart Disease
How Artificial Sweeteners Could Be Linked to Heart Disease
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Active Aging: Preventing Heart Failure in Older Women with Exercise
Active Aging: Preventing Heart Failure in Older Women with Exercise
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Implementing LDL-C—Lowering Therapy: Conversations with the Care Team
Implementing LDL-C—Lowering Therapy: Conversations with the Care Team
Critical Considerations of Residual CV Risk in Patients With T2D & ASCVD
Critical Considerations of Residual CV Risk in Patients With T2D & ASCVD
Strategies for CV Risk Reduction in Complex T2D Patients
Strategies for CV Risk Reduction in Complex T2D Patients